Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inherited Bleeding Disorders in Children”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableStudy completedNCT04406519
What this trial is testing

Evaluation of Static Postural Balance in Children With Hemophilia and Its Relationship With Joint Health

Who this might be right for
HemophiliaArthropathy of KneeArthropathy of Ankle or Foot
Necmettin Erbakan University 42
Large-scale testing (Phase 3)Study completedNCT01467427
What this trial is testing

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 25
Large-scale testing (Phase 3)Study completedNCT02246894
What this trial is testing

Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.

Who this might be right for
Haemophilia A
Bio Products Laboratory
Large-scale testing (Phase 3)Study completedNCT01138501
What this trial is testing

Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 65
Not applicableStudy completedNCT02797353
What this trial is testing

Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan

Who this might be right for
Antepartum HemorrhagePostpartum HemorrhageAnemia+5 more
Aga Khan University 15,000
Not applicableStudy completedNCT04876365
What this trial is testing

A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

Who this might be right for
Hemophilia A
Takeda 153
Not applicableStudy completedNCT00001927
What this trial is testing

Study of Abnormal Blood Clotting in Children With Stroke

Who this might be right for
AbnormalitiesBlood Coagulation DisorderBrain Disease+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 130
Not applicableStudy completedNCT05248594
What this trial is testing

Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

Who this might be right for
Hemophilia A
Montefiore Medical Center 71
Not applicableStudy completedNCT05895032
What this trial is testing

Trial of an Exercise Intervention for Children With Haemophilia

Who this might be right for
HemophiliaChild, OnlyMusculoskeletal Diseases or Conditions
East Kent Hospitals University NHS Foundation Trust 132
Post-approval studies (Phase 4)UnknownNCT02999308
What this trial is testing

A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children

Who this might be right for
Haemophilia
Beijing Children's Hospital 40
Large-scale testing (Phase 3)Study completedNCT00037557
What this trial is testing

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Large-scale testing (Phase 3)Ended earlyNCT00759655
What this trial is testing

Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 1
Testing effectiveness (Phase 2)UnknownNCT01105546
What this trial is testing

RFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors

Who this might be right for
Hemophilia A With Inhibitors
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 50
Post-approval studies (Phase 4)UnknownNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95